LISTE DES ANALYSES HORS-QUEBEC List for testing done out of Québec LABORATOIRE CLINIQUES CUSM MUHC CLINICAL LABS

Size: px
Start display at page:

Download "LISTE DES ANALYSES HORS-QUEBEC List for testing done out of Québec LABORATOIRE CLINIQUES CUSM MUHC CLINICAL LABS"

Transcription

1 APPELATION APPROUVÉE DE OU DE LA MALADIE 11-ß-prostaglandin F2α 21-Hydroxylase Antibodies, Serum [OH21] 68kD (hsp-70) [F68KD] a1-acid glycoprotein autoimmume adrenal failure autoimmune hearing loss Obsolete name: orsomucoid urine, collect 4 C, 25 ml 50% Hac Red Top; store serum frozen Red Top (preferred); Gold SST. Store at -20 C. serum Available at CHUM qualitative antibody test Hospitals In Common ABCC6 Gene Analysis in Pseudoxanthoma Elasticum ABCC6 (603234) Pseudoxanthoma Elasticum (264800) Tier 1: sequencing for commom mutations [2641]; Tier 2: full gene sequencing [2642]; del/dupl (MLPA) [906] GeneDx ( Acetaminophen Acetazolamide Acetylcholine Receptor Antibody quantitation; to determine clearance serum Red Top (not SST) Red Top; Gold SST. Store and send serum at -20 C. RIA Hospitals-In-Common Hospitals-In-Common Acides biliaires totaux [30535] bile salts Serum, fasting; Separate; Stable 1 week at 4 C or Store frozen Bio-Quant (enzymatic) CHUM (ST. LUC) Adalimumab Humira Serum. Stable 48 h at RT, 5 days at 4 C, or 30 days at -20 C. ELISA Gamma-Dyncare Adenosine Deaminase levels Green top (Na or Li heparin). Maintain at room tempertaure. Immunology Service Laboratory. Hospital for Sick Children ADH Gold SST Sacre Coeur ADmark Phospho-Tau/Total-Tau/Ab42 CSF Analysis & Interpretation (Symptomatic) [177] Alzheimer Disease (104300) Cerebrospinal Fluid (CSF), 2 ml. Store at -20 C. ELISA ( File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 1 of 57

2 APPELATION APPROUVÉE DE OU DE LA MALADIE Adrenal hyperplasia due to 21-hydroyxlase deficiency (201910) CYP21A2 (613815) sequencing & MLPA Alberta Mol Dx Laboratory (Calgary) Adrenal hyperplasia, congenital, due to steroid 11-betahydroxylase deficiency; Hypoaldosteronism congenital due to CMO I deficiency CYP11B1 (610613); CYP11B2 (124080) 1. single exon testing 2. full gene sequencing 3. deletion/duplication testing Centogene AG ( AGXT Gene, Full Gene Analysis [AGXMS] AGXT (604285) Hyperoxaluria, primary, type 1 (259900) and MLPA ALPHA-1-ANTITRYPSIN DEFICIENCY (613490) SERPINA1 (104400) ALPHA-1- ANTITRYPSIN DEFICIENCY (613490) Attn: Norine Freedman or Lynn Coleman Special Chemistry Laboratory St Paul s Hospital 1081 Burrard Street Vancouver, B.C. V6Z 1Y6. Contact Dr. A. Mattman BEFORE sending sample. alpha-actin (skeletal muscle form)-related myopathy via the ACTA1 gene [358] ACTA1 (102610) nemaline myopathy (NEM3; OMIM #161800) and congenital fiber-type disproportion (CFTD1; OMIM #255310) ( Alpha-Subunit Pituitary Tumor Marker, Serum [APGH] Alternate name: Alpha Glycoprotein Subunit Red top Alzheimer disease, early form (104300) PSEN1 (104311) ALZHEIMER DISEASE, FAMILIAL, 1 (104300) and MLPA Labor MVZ Westmecklenberg ( Alzheimer disease, early form (104300) PSEN2 (600759) ALZHEIMER DISEASE, FAMILIAL, 1 (104300) Labor MVZ Westmecklenberg ( File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 2 of 57

3 APPELATION APPROUVÉE DE OU DE LA MALADIE Alzheimer disease, early form (104300) APP (104760) ALZHEIMER DISEASE, FAMILIAL, 1 (104300) and MLPA Labor MVZ Westmecklenberg ( Aminolevulinic Acid Dehydratase (ALAD), Whole Blood [ALAD ] Aminolevulinic Acid Dehydratase Deficiency Porphyria (612740) Green Top, 4 C only Amphiphysin Paraneoplastic Disease Profile Gold SST Mitogen Advanced Diagnostics AMYOTROPHIC LATERAL SCLEROSIS PANEL [155] ANG (105850); C9orf72 (614260); FUS (137070); OPTN (602432); SOD1 (147450); TARDBP (605078) Frontotemporal Dementia And/Or Amyotrophic Lateral Sclerosis (105550), Amyotrophic Lateral Sclerosis Type 6 (608030); Amyotrophic Lateral Sclerosis Type 9 (611895); Amyotrophic Lateral Sclerosis Type 1 (105400); Amyotrophic Lateral Sclerosis Type 10 (612069); Amyotrophic Lateral Sclerosis Type 12 (613435) and acgh ( Antdiuretic Hormome Plasma (EDTA); handle at 4 C; freeze plasma in plastic container Hopital Sacre-Coeur, QC File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 3 of 57

4 APPELATION APPROUVÉE DE OU DE LA MALADIE Anti-C1q Antibody, IgG [ANTI-C1Q] Serum separator tube. Separate serum from cells ASAP or within 2 hours of collection. Transfer 0.5 ml serum to an ARUP Standard Transport Tube. (Min: 0.15 ml). Store at 4 C. Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles) Semi-Quantitative Enzyme-Linked Immunosorbent Assay ARUP Laboratories ( Anticorps anti-21 hydroxylase Anti-Enterocyte Antibody autoimmume adrenal failure Gold SST; store serum at -20 C Serum CHUM The Children's Hospital of Philadelphia Anti-HMGCR statin-related myopathy Gold SST Mitogen Advanced Diagnostics Anti-myelin associated glycoproteins (anti- MAG) WB Anti-p140/p155/TRIM28 Anti-PLA2R Paraneoplastic Disease Profile idiopathic membranous nephropathy Gold SST Gold SST Gold SST; store serum at -20 C Mitogen Advanced Diagnostics Mitogen Advanced Diagnostics Mitogen Advanced Diagnostics Anti-RNA pol I/III Gold SST Mitogen Advanced Diagnostics Apert/Pfeiffer Syndrome (recurrent mutation in FGFR1 gene) FGFR1 (136350); FGFR2 (176943) Craniosynostosis: Apert syndrome (101200), Pfeiffer syndrome (101600) : FGFR2 (exon 7); FGFR1 (p.pro252arg) Molecular Genetics Laboratory, Hospital for Sick Children ( ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 4 of 57

5 APPELATION APPROUVÉE DE OU DE LA MALADIE Ataxia/Episodic Ataxia Disorders NextGen DNA Sequencing Panel (33 genes; includes whole mtdna sequencing) [NGS324] ABCB7 (300135); ADCK3 (606980); AFG3L2 (604581); APTX (606350); ATM (607585); CACNA1A (601011); CACNB4 (601949); CLPP (601119); CSTB (601145); FGF14 (601515); FLVCR1 (609144); FXN (606829); HARS2 (600783); ITPR1 (147265); KCNA1 (176260); KCNC3 (176264); KCND3 (605411); LARS2 (604544); MTPAP (613669); OPA1 (605290); PDYN (131340); PRKCG (176980); SACs (604490); SETX (608465); SIL1 (608005); SLC1A3 (600111); SPTBN2 (604985); SYNE1 (608441); TDP1 (607250); TGM6 (613900); TPP1 (607998); TTBK2 (611695); VAMP1 (185880) NextGen Sequencing Medical Neurogenetics ( Autoimmune Dysautonomia Evaluation, Serum (ADE) Autoimmune Inflammatory Myopathy/Myositis Profile Jo-1, Mi2, PL7, PL12, Pm/Scl75, PM/Scl100, Ku, SRP, Ro52, EJ, OJ Red Top Gold SST IFA, RIA, EIA, WB, CBA Mitogen Advanced Diagnostics Autoimmune Neurological Diseases Profile GM1 (IgG,IgM), GM2, GD1a, GT1b (IgG,IgM), GM3 (IgG, IgM), GQ1b (IgG,IgM), GD1b (IgG,IgM) Gold SST Mitogen Advanced Diagnostics File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 5 of 57

6 APPELATION APPROUVÉE DE OU DE LA MALADIE Autoimmune Paraneoplastic Diseases Profile (paraneoplastic ataxia, encephalomyelitis) Autoimmune polyendocrinopathy syndrome, type I (240300) Autosomal dominant lateral temporal lobe epilepsy (Epilepsy, familial temporal lobe, 1) (600512) Amphiphysin, Ri, Yo. Hu, PNMA2 (Ma2/Ta), CV2/CRMP-5, Recoverin, SOX1, tintin Gold SST; CSF Mitogen Advanced Diagnostics AIRE (607358) GeneDx LGI-1 (604619) 1. single exon testing 2. full gene sequencing 3. deletion/duplication testing Centogene AG ( AUTOSOMAL RECESSIVE LIMB GIRDLE MUSCULAR DYSTROPHY SANGER SEQUENCING PANEL (253600; ;254130;607155;611307; ; ; ; ; ; ; ) [360] SGCD (601411); TRIM32 (602290); SGCG (608896); CAPN3 (114240); DYSF (603009); FKFP (606596); SGCA (60119); SGCB (600900); TTN (188840); TCAP (604488); ANO5 (608662) Separate serum from cells ASAP or within 2 hours of collection. Transfer 0.5 ml serum to an ARUP Standard Transport Tube. (Min: 0.15 ml) ( Avian Precipitins: Budgie Red Top; Gold SST Counter Immunoelectrophoresis Hospitals-In-Common Avian Precipitins: Chicken Red Top; Gold SST Counter Immunoelectrophoresis Hospitals-In-Common Avian precipitins: Pigeon Red Top; Gold SST Azithromycin TDM Serum Baller-Gerold syndrome (218600) RECQL4 (603780) Barium Alternate: Hospitals-In- Common Urine - metal free container Counter Immunoelectrophoresis 1. single exon testing 2. full gene sequencing 3. deletion/duplication testing Hospitals-In-Common National Jewish Health Laboratories Centogene AG ( INSPQ File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 6 of 57

7 APPELATION APPROUVÉE DE OU DE LA MALADIE LISTE DES ANALYSES HORS-QUEBEC Basal ganglia calcification, idiopathic, 3 (614540) SLC20A2 (158378) 1. single exon testing 2. full gene sequencing 3. deletion/duplication testing Centogene AG ( Benign Recurrent Intrahepatic Cholestasis Type 2 (605479) ABCB11 (603201) Cinncinatti Children's Hospital (Division of Human Genetics Diagnostic Laboratories) Birt-Hogg-Dubé Syndrome (135150) FLCN (607273) Alberta Mol Dx Laboratory (Calgary) Birt-Hogg-Dubé Syndrome (135150) FLCN (607273) deletion/duplication Alberta Mol Dx Laboratory (MLPA) (Calgary) Breast-Ovarian Cancer, Familial, type 1 (604370) BRCA1 (113705) Mount Sinai Hospital Breast-Ovarian Cancer, Familial, type 2 (612555) BRCA2 (600185) Mount Sinai Hospital Bromide C1 Esterase Inhibitor: Functional Plasma (Citrate).Separate and freeze as soon as possible. Store and send frozen. Specify "Functional" on requisition. Radial immunodiffusion Hospitals-In-Common C1q Complement Component. Separate platelet-poor plasma immediately. Freeze as soon as possible. Store and send frozen. If the specimen thaws, it is unsuitable for analysis. Formerly at Hospitals-In- Common, now available at CHUQ C9ORF72 (FTD) DNA Test [209] C9orf72 (614260) Amyotrophic lateral sclerosis and/or frontotemporal dementia repeat expansion ( CACNA1A Full Gene Sequencing Analysis [MOL033] CACNA1A (601011) Familial hemiplegic migraine 1 (141500); episodic ataxia type 2 (108500) Medical Neurogenetics ( File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 7 of 57

8 APPELATION APPROUVÉE DE OU DE LA MALADIE CACNA1S DNA Sequencing Test [641] CACNA1S (114208) Hypokalemic Periodic Paralysis (HOKPP) full gene sequencing ( CACNB4 Full Gene Sequencing Analysis [MOL227] CACNB4 (601949) Episodic ataxia, type 5 (613855) CADASIL (125310) NOTCH3 (600276) Calpain 3 DNA Sequencing Test CAPN3 (114240) LGMD2A (253600), Calpainopathy Medical Neurogenetics ( London Laboratories Service Group ( Calprotectine fécale [30536] random stool L'Hôpital Maisonneuve-Rosement Carnitine Palmitoyltransferase II (CPT2) Deficiency CPT2 (600650) Myopathy due to CPT II deficiency (255110) Lavender-top (EDTA) tube CPT2 Gene Sequencing (334) [] GeneDx CASPR2 Antibody Test Paraneoplastic Disease Red Top or Gold SST Cathartic Laxatives Profile, Stool [FCLPS] Mg, Pi Stool CAVEOLINOPATHY TESTING VIA THE CAV3 GENE [467] CDKN2A (p16) & CDK4 (Exon2) Sequencing CAV3 (601253) CDKN2A (600160); CDK4 (123829) Muscular Dystrophy, Limb-Girdle, Type 1C (607801) Melanoma, cutaneous malignant, 3 ( ( GeneDx CEREBRAL CAVERNOUS MALFORMATIONS SANGER SQUENCING PANEL [120] KRIT (604214), CCM2 (607292), PCCD10 (609118) Cerebral Cavernous Malformations 1(116860), Cerebral Cavernous Malformations 2 (603284), Cerebral Cavernous Malformations 3 (603285) 1. CCM2 Sanger Sequencing 2. PDCD10 Sanger Sequencing 3. KRIT1 Sanger Sequencing 4. CCM2 Targeted Deletion via PCR ( File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 8 of 57

9 APPELATION APPROUVÉE DE OU DE LA MALADIE CEREBRAL CAVERNOUS MALFORMATIONS VIA THE CCM2 GENE (603284) [122] CCM2 (607929) Cerebral calvernous malformations-2 ( CEREBRAL CAVERNOUS MALFORMATIONS VIA THE KRIT1/CCM1 GENE [121] KRIT1 (604241) Cerebral calvernous malformations-1 (116860) ( CEREBRAL CAVERNOUS MALFORMATIONS VIA THE PDCD10/CCM3 (603285) [123] PDCD10 (609118) Cerebral calvernous malformation-3 ( Cerebrotendinous xanthomatosis (213700) CYP27A1 (606530) 1. single exon testing 2. full gene sequencing 3. deletion/duplication testing Centogene AG ( File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 9 of 57

10 APPELATION APPROUVÉE DE OU DE LA MALADIE CHARCOT MARIE TOOTH DISEASE; 42 GENES + MTDNA [NGS345] AARS (601065); AIFM1 (300169); ARHGEF10 (608236); BAG3 (603883); BSCL2 (606158); CTDP1 (604927); DHTKD1 (614984); DNM2 (602378); EGR2 (129010); FGD4 (611104); FIG4 (609390); GAN (605379); GARS (600287); GDAP1 (606598); GJB1 (304040); GNB4 (610863); HINT1 (601314); HK1 (142600); HSPB1 (602195); HSPB8 (608014); INF2 (610982); KARS (601421); KIF1B (605995); LITAF (603795); LMNA (150330); LRSAM1 (610933); MED25 (610197); MFN2 (608507); MPZ (159440); MTMR2 (603557); NDRG1 (605262); NEFL (162280); PDK3 (602526); PMP22 (601097); PRPS1 (311850); PRX (605725); RAB7A (602298); SBF2 (607697); SH3TC2 (608206); SLC12A6 (604878); TFG (602498); TRPV4 (605427); YARS (603623) Charco-Marie tooth Disease (302800) Next-Generation sequencing Medical Neurogenetics ( Charcot-Marie-Tooth disease, type 2A2 (609260) MFN2 (608507) Charcot-Marie-Tooth neuropathy, X-linked dominant (302800) GJB1 (304040) File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 10 of 57 Charcot-Marie-Tooth Type 1A (118220) PMP22 (601097) deletion/duplication Charcot-Marie-Tooth Type 1A (118220) PMP22 (601097) London Health Sciences Centre, Molecular Diagnostic Laboratory Laboratory of Human Genetics (QC) Laboratory of Human Genetics (QC) Alberta Mol Dx Laboratory (Calgary)

11 APPELATION APPROUVÉE DE OU DE LA MALADIE LISTE DES ANALYSES HORS-QUEBEC Charcot-Marie-Tooth Type 1B (118200) MPZ (159440) Cholestanol Cerebrotendinous xanthomatosis Chondrosarcoma/Exostoses, multiple, type 1 and 2 EXT1 (608177); EXT2 (608210) and MLPA Alberta Mol Dx Laboratory (Calgary) Kennedy Kreiger Institute (Biochemical Genetics) Molecular GeneticsLlaboratory - BC Children s Hospital & BC Women s Hospital CLCN1 DNA Sequencing Test [128] CLCN1 (118425) Cockayne syndrome ERCC6 (609413); ERCC8 (609412) Myotonia congenita ( and ) COL4A5 Sequencing and Deletion Analysis (755) COL4A5 (303630) Alport syndrome (301050) Collagen Type II Antibodies [FFTYC] Red Top; Gold SST. Stable for 7 d at 4 C or longer at -20 C. and del/dupl Enzyme Linked Immunosorbent Assay (ELISA) ( DNA Diagnostic Lab - Boston Children's Hospital ( Colorectal cancer (Li-Fraumeni syndrome) (151623) TP53 (191170) gene dosage Molecular Genetics Laboratory, Hospital for Sick Children ( ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) Complement Based Renal Disease (C3 Sequencing) C3 (120700) Hemolytic uremic syndrome, atypical, susceptibility to, 5 (612925). Part of Panel B: C3, THBD, APLN Molecular Genetics Laboratory, Hospital for Sick Children ( ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 11 of 57

12 APPELATION APPROUVÉE DE OU DE LA MALADIE Complete PKD Evaluation [761] PKD1 (601313); PKD2 (173910) Polycystic kidney disease, adult type 1 (173900); Polycystic kidney disease 2 (613095) PKD1 and PKD2 DNA Sequencing and Deletion Analysis ( Complete Tuberous Sclerosis Evaluation [TSC1 DNA Seq., TSC1 Deletion, TSC2 DNA Seq., TSC2 Deletion] [556] TSC1 (605284); TSC2 (191092) Tuberous sclerosis-1 (191100); Tuberous sclerosis-2 (613254) and del/dupl ( File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 12 of 57

13 APPELATION APPROUVÉE DE OU DE LA MALADIE Comprehensive Intellectual Disability NextGen DNA Sequencing Panel (191 genes; includes whole mtdna sequencing) [NGS325] AAAS (605378); ABCC8 (600509); ACADSB (600301); ACSL4 (300157); ADSL (608222); AFF2 (300806); AGTR2 (300034); ALDH5A1 (610045); ANK3 (600465); AP1S2 (300629); ARHGEF6 (300267); ARHGEF9 (300429); ARID1A (603024); ARID1B (614556); ARX (300382); ASMT (300015); ASPM (605481); ATIC (601731); ATP6AP2 (300556); ATP7A (300011); ATRX (300032); AUTS2 (607270); BCOR (300485); BRAF (164757); BRWD3 (300553); C3orf58 (612200); CACNA1F (300110); CACNG2 (602911); CASK (300172); CC2D1A (610055); CDH15 (114019); CDK5RAP2 (608201); CDKL5 (300203); CENPJ (609279); CHD8 (610528); CLIC2 (300138); CLPP (601119); CNTN3 (601325); CNTN4 (607280); CNTNAP2 (604569); CRADD (614499); CRBN (609262); CUL4B (300304); DAB1 (603448); DCX (300121); DKC1 (300126); DLG3 (300189); DLGAP2 (605438); DOCK8 (611432); DRD2 NextGen Sequencing Medical Neurogenetics ( File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 13 of 57

14 APPELATION APPROUVÉE DE OU DE LA MALADIE CONGENITAL MUSCULAR DYSTROPHY NEXTGEN SEQUENCING (NGS) PANEL [1301] ITGA7 (600536); FKTN (607440); FKRP (606596); (LAMA2 (156225); LARGE (603590); POMT1 (607426); POMT2 (607439); POMGNT1 (606822); DAG1 (128239); DPM1 (603503); DPM3 (605951); CHKB (612395); ISPD (614631); LMNA (150330); GTDC2 (614828); TMEM5 (605862); B3GALNT2 (610194); GMPPB (615320); B3GNT1 (605517); GOSP2 (604027); SGK196 (615247); ST3GAL4 (104240) Muscular Dystrophy- Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A, 10; MDDGA10 (615041); Congenital Disorder Of Glycosylation Type 1E (608799); Congenital Disorder Of Glycosylation Type 1O( ); Muscular dystrophydystroglycanopathy (limbgirdle), type C, 14(615352);Muscular dystrophydystroglycanopathy (congenital with brain and eye anomalies), type A, 12 (615249) Muscular dystrophydystroglycanopathy (congenital with brain and eye anomalies), type A, 13 (615287); Muscular dystrophydystroglycanopathy (congenital with brain and eye anomalies, type A, 11 (615181); Congenital Muscular Dystrophy- Dystroglycanopathy (With Brain And Eye NextGen Sequencing (22 genes) ( File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 14 of 57

15 APPELATION APPROUVÉE DE OU DE LA MALADIE CONGENITAL MYASTHENIC SYNDROME NEXTGEN SEQUENCING (NGS) PANEL [1323] COLQ (603033); CHRNA1 (100690); CHRNB1 (100710); CHRND (100720); CHRNE (100725); MUSK (601296); CHAT (118490); DOK7 (610285); RAPSN (601592); SCN4A (603967) Congenital Myasthenic Syndrome, Acetazolamide- Responsive (614198); Myasthenic Syndrome, Congenital, Associated With Episodic Apnea (254210); Myasthenic Syndrome, Congenital, Associated With Acetylcholine Receptor Deficiency (608931);Myasthenic Syndrome, Congenital, Fast-Channel (608930); Congenital Myasthenic Syndrome, Slow Channel (601462) Next-gen Sequencing ( Cortical Brain Malformations Panel [698] ARFGEF2 (605371), ARX (300382), DCX (300121), EOMES (604615), FKRP (606596), FKTN (607440), FLNA (300017), GPR56 (604110), LAMC3 (604349), LARGE (603590), NDE1 (609449), OCLN (602876), PAFAH1B1 (601545), POMGNT1 (606822), POMT1 (607423), POMT2 (607439), RELN (600514), SRPX2 (300642), TUBA1A (602529), TUBA8 (605742), TUBB2B (612850), TUBB3 (602661), VLDLR(192977) Lisencephaly: Lissencephaly and subcortical band heterotopia (SBH), Alphadystroglycanopathies, Periventricular nodular heterotopia (PVNH); Polymicrogyria Exon Array CGH, Next-gen Sequencing GeneDx File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 15 of 57

16 APPELATION APPROUVÉE DE OU DE LA MALADIE Cortisol, free [FCORT] Red Top or Craniosynostosis Non-Syndromic (select exons of FGFR3 gene) FGFR3 (134934) Craniosynostosis ; FGFR3 (p.pro250arg) Molecular Genetics Laboratory, Hospital for Sick Children ( ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) Creatine Disorders Panel, Urine [CRDPU] GATM (602360); SLC6A8 (300036) arginine:glycine amidinotransferase deficiency (602360/612718), guanidinoacetate methyltransferase deficiency (601240/612736), creatine transporter (SLC6A8) defect (300036/300352) Random urine Crouzon Syndrome (select exons of FGFR2 and FGFR3 gene) FGFR2 (176943); FGFR3 (134934) Craniosynostosis: Crouzon syndrome (123500) : FGFR2 (exon 7 and 8); FGFR3 (p.pro250arg) Molecular Genetics Laboratory, Hospital for Sick Children ( ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 16 of 57

17 APPELATION APPROUVÉE DE OU DE LA MALADIE Cryoglobulin and Cryofibrinogen Panel, Serum and Plasma [CRGSP] CSF Protein Immunoassay Panel Evaluating patients with vasculitis, glomerulonephritis, and lymphoproliferative diseases Evaluating patients with macroglobulinemia or myeloma in whom symptoms occur with cold exposure Creutzfeldt-Jakob Disease (CJD) Cryofibrinogen Collection Container/Tube: Submission Container/Tube: Plastic vial Specimen Volume: 1 ml Collection Instructions: 1. Tube must remain at 37 degrees C. 2. Centrifuge at 37 degrees C. (Do not use a refrigerated centrifuge. If absolutely necessary, ambient temperature is acceptable.) It is very important that the specimen remain at 37 degrees C until after separation of plasma from red cells. 3. Place plasma into an appropriately labeled plastic vial. Cryoglobulin Collection Container/Tube: Red top Submission Container/Tube: Plastic vial Specimen Volume: 5 ml Collection Instructions: 1. Tube must remain at 37 degrees C. 2. Allow blood to clot at 37 degrees C. 3. Centrifuge at 37 degrees C. (Do not use a refrigerated centrifuge If absolutely 2.0 ml CSF; Freeze sample as soon as possible after collection. Ship frozen on dry ice. immunofixation protein testing of cerebrospinal fluid (CSF); S100 protein ELISA: Tau protein ELISA National Microbiology Laboratory, Health Canada (Winnipeg) File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 17 of 57

18 APPELATION APPROUVÉE DE OU DE LA MALADIE Currarino syndrome MNX1 (142994) Currarino syndrome (176450) Diagenos ( CV2/CRMP-5 Paraneoplastic Disease Profile Gold SST Mitogen Advanced Diagnostics Cystatin C Serum Hospitals-In-Common Cystic Fibrosis (219700) CFTR (602421) gene dosage Molecular Genetics Laboratory, Hospital for Sick Children ( ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) Cystinuria SCL3A1 (104614) Cystinuria (220100) Centogene AG ( Cystinuria SCL7A9 (604144) Cystinuria (220100) Centogene AG ( Cystinuria PREPL (609577) Cystinuria (220100) Centogene AG ( Cytochrome P450 2D6 (CYP2D6) Comprehensive CYP2D6 (124030) Cascade, Blood [2D6CB] Dabigratan Serum (Light blue top) Quest Diagnostics DARS2 Full Gene Sequencing Analysis [MOL094] DARS2 (610956) Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation (611105) Alternate name: DARS2: Mitochondrial Aspartyl-tRNA Synthetase Deficiency Medical Neurogenetics ( Deletion 1p Chromosome1p36 deletion syndrome (607872) Green Top; RT only microarray Cytogenetics Laboratory, Hospital for Sick Children File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 18 of 57

19 APPELATION APPROUVÉE DE OU DE LA MALADIE Desmoglein 1 (DSG1) and Desmoglein 3 (DSG3), Serum [DSG13] Pemphigus Red Top Screening test or monitoring patient with confirmed diagnosis Dexamethasone [FDXM] Red Top Dihydrotestosterone Red Top or Gold Top Hospitals-In-Common File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 19 of 57

20 APPELATION APPROUVÉE DE OU DE LA MALADIE DISTAL HEREDITARY MOTOR NEUROPATHY NEXTGEN SEQUENCING (NGS) PANEL [1359] ATP7A (300011); BSCL2 (606158); DCTN1 (601143); DNMT1 (126375); FIG4 (609390); GAN (605379); GARS (600287); HINT1 (601314); HSPB1 (602195); HSPB8 ( ; IGHMBP2 (600502); LAS1L (0) MEGF10 (612453); REEP1 (609139); SETX (608465); SLC5A7 (608761); TRPV4 (605427) Distal Hereditary Motor Neuronopathy Type 2B (608634); Charcot-Marie- Tooth Disease Type 2F (606595); Distal Hereditary Motor Neuronopathy Type 2A (158590); Charcot-Marie- Tooth Disease, Type 2L (608673); Distal Hereditary Motor Neuronopathy Type 5 (600794); Charcot-Marie- Tooth Disease Type 2D (601472); Spastic Paraplegia 17 (270685); Spinocerebellar Ataxia Autosomal Recessive 1 (606002);Charcot-Marie- Tooth Disease Type 2C (606071); Spinal Muscular Atrophy, Distal, Congenital Nonprogressive (600175) ; Scapuloperoneal Spinal Muscular Atrophy (181405); NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB; HMN7B (607641);Perry Syndrome (168605); Charcot Marie Tooth Next Generation Sequencing (NGS) and technologies ( File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 20 of 57

21 APPELATION APPROUVÉE DE OU DE LA MALADIE Diuretic Screen, Urine [FDIRU] LISTE DES ANALYSES HORS-QUEBEC benzthiazide, bumetanide, chlorothiazide, chlorthalidone, furosemide, hydrochlorothiazide, hydroflumethiazide, and metolazone Random urine Drug Screen, Prescription/OTC, Urine [PDSU] Trifluoperazine (stelazine) Random urine Duchenne and Becker Muscular Dystrophy ( and ) DMD (300377) gene dosage Molecular Genetics Laboratory, Hospital for Sick Children ( ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) Ehlers-Danlos syndrome, type I COL5A2 (120190) Connective Tissue Gene Test Ehlers-Danlos syndrome, type I and II COL5A1 (120215) Connective Tissue Gene Test Ehlers-Danlos syndrome, type I and II COL5A1 (120215) del/dupl Connective Tissue Gene Test Ehlers-Danlos syndrome, type IV (130050) COL3A1 (120180) Epidermolysis bullosa (226600) COL7A1 (120120) & del/dupl 1. single exon testing 2. full gene sequencing 3. deletion/duplication testing Connective Tissue Gene Tests Centogene AG ( Epilepsy, generalized, with febrile seizures plus, type 7 (613863) SCN9A (603415) 1. single exon testing 2. full gene sequencing 3. deletion/duplication testing Centogene AG ( File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 21 of 57

22 APPELATION APPROUVÉE DE OU DE LA MALADIE Epilepsy,comprehensive; 126 genes + mtdna [NGS385] ABAT (137150); ABCC8 (600509); ACADSB (600301); ACSF3 (614245); ADSL (608222); ALDH5A1 (610045); ALDH7A1 (107323); ALG11 (613666); ARHGEF9 (300429); ARX (300382); ATIC (601731); ATP6AP2 (300556); AUTS2 (607270); BOLA3 (613183); C10ORF2 (606075); CACNA1A (601011); CACNA1H (607904); CACNA2D2 (607082); CACNB4 (601949); CDKL5 (300203); CHRNA2 (118502); CHRNA4 (118504); CHRNB2 (118507); CLCN2 (600570); CLN3 (607042); CLN5 (608102); CLN6 (606725); CLN8 (607837); CNTNAP2 (604569); COG7 (606978); COG8 (606979); COL6A2 (120240); COQ2 (609825); COQ9 (612837); CPA6 (609562); CSTB (601145); CTSD (116840); D2HGDH (609186); DNAJC5 (611203); DPAGT1 (191350); DYRK1A (600855); EFHC1 (608815); EPM2A (607566); ETHE1 (608451); FARS2 (611592); FASTKD2 (612322); FH (136850); FOLR1 (136430); FOXG1 (164874); GABRA1 NextGen Sequencing Medical Neurogenetics ( File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 22 of 57

23 APPELATION APPROUVÉE DE OU DE LA MALADIE Erythrocytosis, family related EPOR (133171), VHL (608537), EGLN1(PHD2) (606425), EPAS1 (HIF2A) (603349) Erythrocytosis, familial, 1 (133100); Erythrocytosis, familial, 2 (263400); Erythrocytosis, familial, 3 (609820); Erythrocytosis, familial, 4 (611783). Panel: EPOR: , VHL: , EGLN1: , EPAS1: MVZ Dortmund Dr. Eberhard and Partner Dortmund, Nordrhein-Westfalen, Germany Ethambutol TDM Serum Everolimus, Blood [EVROL] TDM National Jewish Health Laboratories File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 23 of 57

24 APPELATION APPROUVÉE DE OU DE LA MALADIE Expanded Neuromuscular Disorders: Sequencing and Deletion/Duplication Panel[MM360] ACTA1, AMPD1, AMPD3, ANO5, BAG3, BIN1, BSCL2, CAPN3, CAV3, CFL2, CHAT, CHRNA1, CHRNB1, CHRND, CHRNE, CHRNG, COL6A1, COL6A2, COL6A3, COLQ, CRYAB, DAG1, DES, DMD, DNM2, DOK7, DYSF, EMD, FHL1, FKRP, FKTN, FLNC, GAA, GLE1, GNE, IGHMBP2, ISPD, ITGA7, LAMA2, LARGE, LDB3, LMNA, MTM1, MTMR14, MUSK, MYH2, MYH7, MYOT, NEB, PABPN1, PLEC, PLEKHG5, PMM2, POMGNT1, POMT1, POMT2, PTRF, PYGM, RAPSN, RYR1, RYR2, SCN4A, SEPN1, SGCA, SGCB, SGCD, SGCE, SGCG, SIL1, SYNE1, SYNE2, TCAP, TNNI2, TNNT1, TPM2, TPM3, TRIM32, TTN, VRK1 Muscular dystrophies, Congenital myopathies, Congenital myasthenic syndrome, Nemaline myopathy, Limb girdle muscular dystrophy, Emery-Dreifuss muscular dystrophy, Congenital muscular dystrophy, Cardiomyopathies, Myoadenylate deaminase deficiency, Erythrocyte AMP deaminase deficiency, Myofibrillar myopathy, Duchenne/Becker muscular dystrophy, Congenital disorder of glycosylation type 1a, Malignant hyperthermia susceptibility, Myoclonus dystonia, Marinesco- Sjogren syndrome, Distal arthrogryposis, NMD, Neuromuscular disorders Next-Generation sequencing and genetargeted CGH array (deletion/duplication analysis included in this panel: BIN1, BSCL2, CFL2, CHAT, CHRNA1, CHRNB1, CHRND, CHRNE, CHRNG, COLQ, DNM2, DOK7, FHL1, FLNC, GLE1, GNE, IGHMBP2, ISPD, MTM1, MTMR14, MUSK, MYH2, PLEKHG5, PTRF, PYGM, RAPSN, SCN4A, SYNE1, SYNE2, and VRK1) Emory Molecular Genetics Laboratory (genetics.emory.edu/egl/) Facioscapulohumeral Muscular Dystrophy (158900) DUX4 (D4Z4) (606009) deletion/duplication FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2 (158901) VIA THE SMCHD1 GENE [874] SMCHD1 (614982) Childern's Hospital of Eastern Ontario ( File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 24 of 57

25 APPELATION APPROUVÉE DE OU DE LA MALADIE Familial Hemophagocytic Lymphohistiocytosis (FHL), Autosomal Recessive; type 2 (603553), type 3 (608898), type 4 (603552) and type 5 (613101) FAMILIAL HYPERCHOLESTEROLEMIA SANGER SEQUENCING PANEL [875] Familial Limb Girdle Myasthenia Syndroma via the DOK7 gene [465] Fascioscapulohumeral Muscular Dystrophy 1A (FSHD) (158900) PRF1 (170280); UNC13D (MUNC13-4) (608897); STXBP2 (601717); RAB27A (603868); STX11 (605014) APOB (143890); LDLR (144010); PCKS9 (603776) DOK7 (610285) FOXC1 Gene Sequencing [1342] FOXC1 (601090) Friedreich's Ataxia DNA Sequencing Analysis [348] FXN (FRDA) (606829) Frontotemporal Dementia Evaluation [281] PRF1 and STX11 also at: Hospital for Sick Children Familial Hypercholesterolemia (143890); Hypercholesterolemia, Autosomal Dominant, Type B (144010); Hypercholesterolemia, Autosomal Dominant, 3 (603776) Myasthenia, Limb-Girdle, Familial (254300) and acgh DUX4 (FSHMD1A) (606009) deletion and haplotype GRN (138945), MAPT (157140), C9ORF72 (614260) Axenfeld-Rieger syndrome, type 3 and Rieger or Axenfeld anomalies (602482) Friedreich ataxia (229300). Hop. Saint- Justin - triplet expansion; North York - triplet expansion Frontotemporal Dementia (600274) Cinncinatti Children's Hospital (Division of Human Genetics Diagnostic Laboratories) ( ( Childern's Hospital of Eastern Ontario GeneDx Lavender-top (EDTA) tube Fumarase deficiency (606812) FH (136850) fumarate hydratase For MAPT and GRN: DNA Sequencing; for C9ORF72: PCR Fragment Analysis by Capillary Electrophoresis and del/dupl ( ( GeneDx File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 25 of 57

26 APPELATION APPROUVÉE DE OU DE LA MALADIE Functional Panel (FH autoantibody, Hemolytic Assay, C3Nef, and soluble C5b-9 (smac)) Panel requires at least 2ml frozen serum & plasma ELSIA and other assays Molecular Otolaryngology & Renal Research Laboratory, U. of Iowa Carver College of Medicine Gabapentin Red Top Hospitals-In-Common GARS Full Gene Sequencing Analysis [MOL167] GARS (600287) Charcot-Marie-Tooth disease, type 2D (601427); Medical Neurogenetics Neuropathy, distal ( hereditary motor, type V (600794) Gaucher Disease (recurrent mutations) GBA (606463) Gaucher's Disease, Type 1 (230800); Gaucher Disease, Perinatal Lethal (608013); Subacute Neuronopathic Gaucher's Disease (230900); Gaucher Disease, Type IIIc (231005) Direct mutation analysis (9 mutations);akj 90% sensitivity; others 50-60% Molecular Genetics Laboratory, Hospital for Sick Children ( ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) GAUCHER DISEASE VIA THE GBA GENE [479] GBA (606463) Gaucher's Disease, Type 1 (230800); Gaucher Disease, Perinatal Lethal (608013); Subacute Neuronopathic Gaucher's Disease (230900); Gaucher Disease, Type IIIc (231005) ( GCK (MODY2) DNA Sequencing and DeletionTest GCK (138079) MODY2, Maturity-Onset Diabetes of Young (MODY) (125851) ( File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 26 of 57

27 APPELATION APPROUVÉE DE OU DE LA MALADIE Gene dosage for FGFR2, FGFR3 & TWIST FGFR2 (176943); FGFR3 (134934); TWIST1 (601622) Craniosynostosis del/dupl Molecular Genetics Laboratory, Hospital for Sick Children ( ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) GFAP Full Gene Sequencing Analysis GFAP (137780) Alexander disease (203450) Medical Neurogenetics ( GH-RH Serum or EDTA plasma InterSceince Institute Gitelman syndrome ( ) SLC12A3 (600968) ( GLA gene dosage GLA (300644) Fabry Disease (301500) ; Store at RT or 4 C for up to 48 h after drawing. At 4 C for >48 h. MLPA Molecular Genetics Laboratory, Hospital for Sick Children ( ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) GLA gene sequencing GLA (300644) Fabry Disease (301500) ; Store at RT or 4 C for up to 48 h after drawing. At 4 C for >48 h. Molecular Genetics Laboratory, Hospital for Sick Children ( ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) Glucagon ; freeze plasma ASAP Hospitals In Common File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 27 of 57

28 APPELATION APPROUVÉE DE OU DE LA MALADIE Glutamic Acid Decarboxylase (GAD65) Antibody Assay, Spinal Fluid [GD65C] stiff-man syndrome, autoimmune cerebellitis and other acquired central nervous system disorders affecting gabaminergic neurotransmission CSF (4 C preferred) Immunoprecipitation Assay Glycogen Storage Disease V (McArdle disease) (232600) PYGM (608455) sequencing and del/dupl and del/dupl Emory Molecular Genetics Laboratory (genetics.emory.edu/egl/) Neurological Disease GQ1b (IgG+IgM) Gold SST Mitogen Advanced Diagnostics Profile Hyperoxaluria, primary, GRHPR Gene, Full Gene Analysis [GRHMS] GRHPR (604296) type II (296000) and. MLPA Haloperidol Red Top or Green Top Hospitals In Common Hearing Loss: Branchio-Oto-Renal (BOR) Syndrome (115630) EYA1 (601653) 1. EYA1 gene sequencing 2. EYA1 gene dossage Molecular Genetics Laboratory, Hospital for Sick Children ( ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) Hearing Loss: Non-Syndromic (Connexin 26 & 30) GJB2 (121011); GJB6 (604418) 1. GJB2 sequencing and GJB6 deletion 2. GJB2 sequencing only Molecular Genetics Laboratory, Hospital for Sick Children ( ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 28 of 57

29 APPELATION APPROUVÉE DE OU DE LA MALADIE Hemiplegic Migraine Evaluation CACNA1A (601011); ATP1A2 (182340); SCN1A (182389) Familial Hemiplegic Migraine Type I (CACNA1A) DNA Test (141500), Familial Hemiplegic Migraine Type II (ATP1A2) DNA Test (602481), Familial Hemiplegic Migraine Type III (SCN1A) DNA Test (Target Exon Analysis) (609634) ( Heparin Induced Thrombocytopenia HEREDITARY BREAST CANCER VIA THE CHEK2 GENE [714] CHEK2 (604373) Hereditary Breast Cancer via the CHEK2 Gene (Li- Fraumeni syndrome) (114480) Red top. 4 ml. Draw blood into red-top vacutainer and allow to clot. Centrifuge and transfer serum to plastic tube. Freeze promptly. Serotonin Release Assay (SRA) and PF4/heparin EIA Platelet Immunology Laboratory, McMaster University ( Hereditary Diffuse Gastric Cance (Gastric cancer, familial diffuse, with or without cleft lip and/or palate) (137215) CDH1 (192090) 1. single exon testing 2. full gene sequencing 3. deletion/duplication testing Centogene AG ( HEREDITARY DIFFUSE GASTRIC CANCER (137215) VIA THE CDH1 GENE [798] CDH1 (192090) ( Hereditary Erythrocytosis Mutations [HEMP] EPOR (133171), VHL (608537), EGLN1(PHD2) (606425), EPAS1 (HIF2A) (603349) Erythrocytosis, familial, 1 (133100); Erythrocytosis, familial, 2 (263400); Erythrocytosis, familial, 3 (609820); Erythrocytosis, familial, 4 (611783). Panel: EPOR: , EGLN1: , EPAS1: , As reflex VHL: File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 29 of 57

30 APPELATION APPROUVÉE DE OU DE LA MALADIE LISTE DES ANALYSES HORS-QUEBEC Hereditary hemochromatosis, type 1 (235200) HFE (613609) 1. single exon testing 2. full gene sequencing 3. deletion/duplication testing Centogene AG ( Hereditary Hemorrhagic Telangiectasia ENG (131195), ACVRL1 (ALK1) (601284), SMAD4 (600993) Telangiectasia, hereditary hemorrhagic, type 1 (187300) (OSLER- RENDU-WEBER DISEASE);Telangiectasia, hereditary hemorrhagic, type 2 (600376); Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome (175050) and MLPA Molecular Genetics Laboratory, Hospital for Sick Children ( ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) Hereditary Hemorrhagic Telangiectasia (HHT), type 1 (187300) and type 2 (600376) ENG (131195); ACVRL1(ALK1) (601284) Lavender 1. ACVRL1 gene sequencing 2.ENG gene sequencing 3. SMAD4 gene sequencing 4. ACVRL1 and ENG gene dosage Molecular Genetics Laboratory, Hospital for Sick Children ( ratorymedicine/laboratories- Services/Molecular-Genetics- Laboratory/index.html) Hereditary Interstitial Kidney Disease (UMOD) DNA Sequencing Test [770] UMOD (191845) Familial juvenile hyperuricemic (or gouty) nephropathy (FJHN) (162000) and Medullary cystic kidney disease type II (MCKD2) (603820) ( Histamine ; freeze plasma ASAP Histoplasma Antibody, Serum [SHSTO] Histoplasmosis Red Top Hospitals In Common File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 30 of 57

31 APPELATION APPROUVÉE DE OU DE LA MALADIE Histoplasma Sereology Gold SST Alberta Provincial Laboratory HLA-B 1502 Genotype, Carbamazepine Hypersensitivity, Blood [HLA15] HNF4A (MODY1) DNA Sequencing and Deletion Test (125850) Holoprosencephaly-7 (610828) /Basal cell nevus syndrome (109400) /Gorlin syndrome HLA-B (142830) HNF1A (TCF1) (142410) PTCH1 (601309) Homocystinuria [1563] CBS (613381) Stevens-Johnson syndrome (608579) and toxic epidermal necrolysis (608579) Homocystinuria, B6- responsive and nonresponsive types (236200) & MLPA and del/dupl 1. 2.HD array HTRA1 DNA Sequencing Test (CARASIL) (600142) HTRA1 (602194) Hypercholestérolémie familiale (gène du récepteur LDL) LDLR (144010) Hyperglycosylated hcg Hyper-IgE Syndrome Panel [678] DOCK8 (614443), SPINK5 (605010), STAT3 (102582), TYK2 (176941) Familial Hypercholesterolemia (143890) First trimester screen for Down syndrome and trisomy 18 Hyper-IgE recurrent infection syndrome {147060); Hyper-IgE recurrent infection syndrome, autosomal recessive (243700); Netherton syndrome (256500); Tyrosine kinase 2 deficiency (611521) Gold SST Exon Array CGH, Next-gen Sequencing ( GeneDx Connective Tissue Gene Tests ( ( Hopital Ste. Justine Quest Laboratories GeneDx ( File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 31 of 57

32 APPELATION APPROUVÉE DE OU DE LA MALADIE Hypertophic Cardiomyopathy Sequencing Panel [192600] ACTC (ACTC1) (102540), CAV3 (601253), GLA (300644), LAMP2 (309060), MTTG (590035), MTTI (590045), MTTK (590060), MTTQ (590030), MYBPC3 (600958), MYH7 (160760), MYL2 (160781), MYL3 (160790), PRKAG2 (602743), TNNC1 (191040), TNNI3 (191044), TNNT2 (191045), TPM1 (191010), TTR (176300) See ( Panel (overlap)., Next Gen sequencing GeneDx HYPERTROPHIC CARDIOMYOPATHY NEXTGEN SEQUENCING (NGS) PANEL [1313] ACTC1 (102540); ACTN2 (102573); CSSRP3 (600824); GLA (300644); LAMP2 (309060); MYBPC3 (600958); MYH7 (160760); MYL2 (160781); MYL3 ( ; PRKAG2 (602743); TNNC1 (191040); TNNI3 (191044); TNNT2 (191045); TPM1 (191010); TTN (188840) See GeneDx Panel (overlap). [2 tubes] Next Generation Sequencing (NGS) and technologies ( Hypokalemic Periodic Paralysis, type 1 (170400) and type 2 (613345) CACNA1S (114208); SCN4A (603967) Sequence analysis of select exons Targeted mutation analysis Molecular GeneticsLlaboratory - BC Children s Hospital & BC Women s Hospital IA-2 Autoantibody Test Diabetes, type 1 Gold SST or Red Top ( IBD sigi Diagnostic differnetiate among IBD types 2.0 ml Serum (Red Top or SST) and 2.0 ml Whole Blood EDTA / Tube Prometheus Therapeutics & Diagnostics Ibuprofen Red Top ARUP Laboratories File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 32 of 57

33 APPELATION APPROUVÉE DE OU DE LA MALADIE IGF Binding Protein-1 (IGFBP-1) [FIGBP] Not: IGFBP-3 Draw blood in a plain, red-top tube(s). Spin down and separate within one hour. Ship 0.5 ml frozen in a plastic vial. IGF-II [FIGF2] Draw blood in a plain, red-top tube(s). Separate within 1 hour of collection,freeze immediately Inclusion body myopathy and autospmal recessive, ealrly onset myopathy via the MYH2 gene [361] MYH2 (160740) Inclusion Body Myopathy 3 (605637) ( Infliximab et Ac anti-infliximab [30098] Serum. Stable 48 h at RT, 5 days at 4 C, or 30 days at -20 C. ELISA L'Hôpital Maisonneuve-Rosement Inherited Focal and Segmental Glomerulosclerosis (FSGS) Evaluation [717] INF2 (601982); TRPC6 (603652); NPHS2 (604766); ACTN4 (604638) Glomerulosclerosis, focal segmental, 5 (613237); Glomerulosclerosis, focal segmental, 2 (603965); Nephrotic syndrome, type 2 ( );Glomerulosclerosi s, focal segmental, 1 (603278) ( Insulin-Like Growth Factor 1 [IGF-1] Red top Royal Victoria Hospital Integrin alpha 9 ITGA9 (603963) Storage/Transport Temperature not available Interferon Beta Neutralizing Antibodies In MS Patient Treated With IFN Gold SST Neuro-Immunology Laboratories (UBC) Interleukin-2 (IL-2), ELISA [FIL2] Draw sufficient blood in a plain, red-top tube(s). Spin down and pour off into a plastic, screwcapped tube. Freeze immediately. ELISA JAG1 Gene Sequencing & Del/Dup JAG1 (601920) Alagille syndrome (118450) GeneDx File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 33 of 57

34 APPELATION APPROUVÉE DE OU DE LA MALADIE LISTE DES ANALYSES HORS-QUEBEC Jaundice Chip multiple genes gene chip Cinncinatti Children's Hospital (Division of Human Genetics Diagnostic Laboratories) Joubert and Meckel-Gruber Syndromes via the CC2D2A gene [278] JUNCTIONAL EPIDERMOLYSIS BULLOSA (JEB) SANGER sequencing panel [975] Juvenile Polyposis Syndrome ( and ) CC2D2A (612013) Joubert syndrome 9 LAMC2 (150292); LAMA3 (600805); LAMB3 (150310); COL17A1 (113811) BMPR1A (601299); SMAD4 (600993) Tier 1: sequencing & del/dupl ( ( Juvenile Polyposis Syndrome ( and ) BMPR1A (601299) Tier 2: sequencing GeneDx Juvenile Polyposis Syndrome ( and ) Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome/juvenile polyposis syndrome, infantile form BMPR1A (601299); SMAD4 (600993) SMAD4 (600993); BMPR1A (601299) GeneDx Tier 3: del/dupl GeneDx Tier 1: sequecning and del/dupl GeneDx KCNA1 Full Gene Sequencing Analysis [MOL064] KCNA1 (176260) Episodic ataxia/myokymia syndrome Medical Neurogenetics ( File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 34 of 57

35 APPELATION APPROUVÉE DE OU DE LA MALADIE LAMINOPATHIES VIA THE LMNA GENE [347] LMNA (150330) Charcot-Marie-Tooth Disease Type 2B1 (605588); Limb-Girdle Muscular Dystrophy, Type 1B (159001); Lipodystrophy, Familial Partial, Dunnigan Type (151660); Dilated Cardiomyopathy 1A (115200); Emery-Dreifuss Muscular Dystrophy, Autosomal Dominan (151350)t; Restrictive Dermopathy, Lethal (275210); Hutchinson- Gilford Syndrome (176670) ( Lebers hereditary optic neuropathy (LHON) (535000) Also available: Alberta Mol Dx Laboratory (Edmonton) (2 x 4 ml) Targeted mutation analysis (nt.#3460g>a, nt.#11778g>a and nt.#14484t>c) London Health Sciences Centre, Molecular Diagnostic Laboratory File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 35 of 57

36 APPELATION APPROUVÉE DE OU DE LA MALADIE Leigh disease and Leigh-like syndromes NextGen DNA Sequencing Panel (75 genes) [NGS351] LEMS (anti-vgcc) Antibody Test [475] Leukemia, Philadelphia chromosome-positive, resistant to imatinib AIFM1 (300169); ALDH5A1 (610045); ARX (300382); BCS1L (603647); C12orf65 (613541); COA5 (613920); COX10 (602125); COX14 (614478); COX15 (603646); COX6B1 (124089); CPT2 (600650); DLAT (608770); DLD (238331); ETHE1 (608451); FARS2 (611592); FASTKD2 (612322); FOXRED1 (613622); GCDH (608801); KCNQ2 (602235); LIAS (607031); LRPPRC (607544); MTFMT (611766); MUT (609058); NDUFA1 (300078); NDUFA10 (603835); NDUFA11 (612638); NDUFA12 (614530); NDUFA2 (602137); NDUFA9 (603834); NDUFAF1 (606934); NDUFAF2 (609653); NDUFAF3 (612911); NDUFAF4 (611776); NDUFAF5 (612360); NDUFAF6 (612392); NDUFB3 (603839); NDUFS1 (157655); NDUFS2 (602985); NDUFS3 (603846); NDUFS4 (602694); NDUFS6 (603848); NDUFS7 (601825); NDUFS8 (602141); NDUFV1 (161015); NDUFV2 (600532); NDUFV3 (602184); NUBPL (613621); PC (608786); ABL1 (189980) Leigh syndrome (256000); Leigh syndrome, X-linked (308930) Lambert-Eaton Myasthenic syndrome Red Top NextGen Sequencing Medical Neurogenetics ( ( University Health Network (Toronto General Hospital) Levetiracetam ; transport on ice Hopital Ste. Justine File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 36 of 57

37 APPELATION APPROUVÉE DE OU DE LA MALADIE LHON mtdna Evaluation Leber's hereditary optic neuropathy (535000); multiple mitochondrial genes involved ( LIMB GIRDLE MUSCULAR DYSTROPHY (LGMD) NEXTGEN SEQUENCING (NGS) PANEL [1345] ANO5 (608662); CAPN3 (114240); CAV3 ( ; DES (125660); DNAJB6 (611332); DYSF (603009); FKRP (606596); GMPPB (615320); ISPD (614631); LIMS2 (607908); LMNA (150330); MYOT (604103); PNPLA2 (609059); SGCA (600119); SGCB (600900); SGCD (601411); SGCG (608896); SMCDH1 (614982); TCAP (604488); TNOP3 (610032); TOR1AIP1 (614512); TRAPPC11 (614138); TRIM32 (602290); TTN (188840) [2 tubes] NextGen Sequencing (24 genes) ( LIMB GIRDLE MUSCULAR DYSTROPHY TYPE 2B AND MIYOSHI MYOPATHY VIA THE DYSF GENE [342] LIMB GIRDLE MUSCULAR DYSTROPHY, TYPE 2L (LGMD2L)(611307) AND DISTAL MIYOSHI MYOPATHY (MMD3) (613319) VIA THE ANO5 GENE [469] DYSF (603009) Limb-Girdle Muscular Dystrophy, Type 2B (253601); Miyoshi Myopathy (254130), Myopathy, Distal, With Anterior Tibial Onset (606768) [2 tubes] ANO5 (608662) Loeys-Dietz syndrome ( and ) TGFBR1 (190181) 1. single exon testing 2. full gene sequencing 3. deletion/duplication testing ( ( Centogene AG ( File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 37 of 57

38 APPELATION APPROUVÉE DE OU DE LA MALADIE LOEYS-DIETZ SYNDROME VIA THE TGFBR2 GENE [397] Long QT Syndrome (LQTS) Sequencing and Gene Duplication Panel (192500) MAG 'Dual Antigen' Autoantibody Test TGFBR2 (190182) AKAP9 (604001), ANK2 (106410), CACNA1C (114205), CAV3 (601253), KCNE1 (176261), KCNE2 (603796), KCNE3 (604443), KCNH2 (152427), KCNJ2 (600681), KCNQ1 (607542), SCN4B (608256), SCN5A (600163), SNTA1 (601017) LISTE DES ANALYSES HORS-QUEBEC Loeys-Dietz syndrome 1B (610168); Loeys-Dietz syndrome 2B (610380) Anti-MAG neuropathy, Anti-SGPG neuropathy 1. Exon Array CGH, Next-gen Sequencing 2. Known mutation (specify mutation) Malignant hyperthermia susceptibility 1 (145600) RYR1 (180901) Mannose-binding protein deficiency MBL2 (154545) Mannose-binding protein deficiency (614372) Red Top deletion/duplication ( GeneDx ( University Health Network (Toronto General Hospital) Centogene AG ( MAPT DNA Sequencing Test [205] MAPT (157140) Frontotemporal Dementia (600274) Marfan syndrome, type I (154700) FBN1 (134797) & del/dupl ( Connective Tissue Gene Tests File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 38 of 57

39 APPELATION APPROUVÉE DE OU DE LA MALADIE Meckel-Gruber syndrome Sequencing Panel CC2D2A (612013); CEP290 (610142); MKS (609883); RPGRIP1L (610937); TCTN (613846)2; TMEM67 (609884); TMEM216 (613877) LISTE DES ANALYSES HORS-QUEBEC Meckel Syndrome, Type 8 (613885); Meckel Syndrome, Type 6 (312284); Meckel Syndrome, Type1 (249000); Meckel Syndrome, Type 4 (611134); Meckel Syndrome, Type 3 (607361); Meckel Syndrome, Type 5 (611561); Meckel syndrome 2 (603194) Melnick-Needles Syndrome (309350) FLNA (300017) MERRF (545000), MELAS (540000), NARP (551500) Mitochondrial DNA Sequencing Analysis, whole [MOL021] Mitochondrial diseases including: Leber hereditary optic neuropathy (LHON); Neuropath, ataxia, and retinitis pigmentosa (NARP); Myoclonic epilepsy associated with ragged-red fibers (MERRF); Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) & del/dupl Targeted mutation analysis NextGen Sequencing University of Chicago Genetic Services Laboratories (dnatesting.uchicago.edu) Emory Molecular Genetics Laboratory (genetics.emory.edu/egl/) Alberta Mol Dx Laboratory (Edmonton) Medical Neurogenetics ( MLPA (screen for deletions of CFHR1-CFHR3) CFHR1 (134371); CFHR3 (605336) Hemolytic uremic syndrome, atypical, susceptibility to (235400) MLPA Molecular Otolaryngology & Renal Research Laboratory, U. of Iowa Carver College of Medicine File Name: Gilfix-Lab Send Out List_Revised Updated sorted Page 39 of 57

LISTE DES ANALYSES HORS-QUEBEC List for testing done out of Québec LABORATOIRE CLINIQUES CUSM MUHC CLINICAL LABS

LISTE DES ANALYSES HORS-QUEBEC List for testing done out of Québec LABORATOIRE CLINIQUES CUSM MUHC CLINICAL LABS 11 Beta-Prostaglandin F2 Alpha, 24 Hour, Urine [BPG2] Systemic mast cell disease Urine. Add to container 25 ml 50% HAc. Collect for 24-h. Refrigeate 4 C during collection. Store frozen. Enzyme Immunoassay

More information

LISTE DES ANALYSES HORS-QUEBEC List for testing done out of Québec LABORATOIRE CLINIQUES CUSM MUHC CLINICAL LABS

LISTE DES ANALYSES HORS-QUEBEC List for testing done out of Québec LABORATOIRE CLINIQUES CUSM MUHC CLINICAL LABS APPELATION APPROUVÉE DE OU DE LA MALADIE ASSOCIÉE 11-ß-prostaglandin F2a urine, collect 4 C, 25 ml 50% Hac 21-Hydroxylase Antibodies, Serum autoimmume adrenal Red Top; store serum failure frozen a1-acid

More information

Comprehensive List of Neuromuscular Disorders Covered by Muscular Dystrophy Canada

Comprehensive List of Neuromuscular Disorders Covered by Muscular Dystrophy Canada Comprehensive List of Neuromuscular Disorders Covered by Muscular Dystrophy Canada Neuromuscular disorders is a general term that refers to diseases that affect any part of the nerve and muscle. These

More information

Neuromuscular diseases

Neuromuscular diseases Neuromuscular diseases Spinal muscular atrophy - SMA characterized by degeneration of the anterior horn cells in the spinal cord and motor nuclei in the lower brainstem. SMA type 1, is also known as Werdnig-

More information

Objectives Role of Medical Genetics in Hearing Loss Evaluation. 5 y.o. boy with severe SNHL

Objectives Role of Medical Genetics in Hearing Loss Evaluation. 5 y.o. boy with severe SNHL Objectives Role of Medical Genetics in Hearing Loss Evaluation Millan Patel, MD UBC Dept. of Medical Genetics October 22, 2010 Case presentation to illustrate importance of defining syndromic hearing loss

More information

DIAGNOSING CHILDHOOD MUSCULAR DYSTROPHIES

DIAGNOSING CHILDHOOD MUSCULAR DYSTROPHIES DIAGNOSING CHILDHOOD MUSCULAR DYSTROPHIES Extracts from a review article by KN North and KJ Jones: Recent advances in diagnosis of the childhood muscular dystrophies Journal of Paediatrics and Child Health

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_epilepsy 1/28/14 10/2015 10/2016 10/2015 Description of Procedure or Service Description

More information

EPILEPSY. www.amplexa.com. Childhood Epilepsy Epilepsy Associated Brain Malformation (EA-BMF40) Progressive Myoclonic Epilepsy

EPILEPSY. www.amplexa.com. Childhood Epilepsy Epilepsy Associated Brain Malformation (EA-BMF40) Progressive Myoclonic Epilepsy EPILEPSY Childhood Epilepsy Epilepsy Associated Brain Malformation (EA-BMF40) Progressive Myoclonic Epilepsy 1 in 10 cases of epilepsy is believed to be hereditary. A clear diagnosis is the first step.

More information

Paraneoplastic Antibodies in Clinical Practice. Mohammed El lahawi New Cross Hospital Wolverhampton

Paraneoplastic Antibodies in Clinical Practice. Mohammed El lahawi New Cross Hospital Wolverhampton Paraneoplastic Antibodies in Clinical Practice Mohammed El lahawi New Cross Hospital Wolverhampton 1 Effects of Neoplasm Direct mass ( pressure ) effect Metastasis effect Remote effect 2 The Nervous System

More information

Management in the pre-hospital setting

Management in the pre-hospital setting Management in the pre-hospital setting Inflammation of the joints Two main types: Osteoarthritis - cartilage loss from wear and tear Rheumatoid arthritis - autoimmune disorder Affects all age groups,

More information

Genetics and Cardiovascular diseases. Majid Alfadhel Geneticist and Pediatrician MD,MHSc,SSC Ped, ABHS(CH), FCCMG

Genetics and Cardiovascular diseases. Majid Alfadhel Geneticist and Pediatrician MD,MHSc,SSC Ped, ABHS(CH), FCCMG Genetics and Cardiovascular diseases Majid Alfadhel Geneticist and Pediatrician MD,MHSc,SSC Ped, ABHS(CH), FCCMG Outlines Basic understanding of cardiovascular genetics Modes of disease inheritance Genetic

More information

Test Information Sheet

Test Information Sheet Test Information Sheet GeneDx 207 Perry Parkway Gaithersburg, MD 20877 Phone: 888-729-1206 Fax: 301-710-6594 E-mail: wecare@genedx.com www.genedx.com/oncology OncoGene Dx: High/Moderate Risk Panel Sequence

More information

Neonatal Hypotonia. Clinical Approach to Floppy Baby

Neonatal Hypotonia. Clinical Approach to Floppy Baby Neonatal Hypotonia Clinical Approach to Floppy Baby Hypotonia in the newborn is a common presenting feature of systemic illness or neurologic dysfunction at any level of the central or peripheral nervous

More information

CLINICAL TEST PRICES BY DISEASE

CLINICAL TEST PRICES BY DISEASE Targeted Testing of Familial Mutations 100 Single exon sequencing of gene $190 200 Double exon sequencing of gene $340 300 Triple exon sequencing of gene $390 Deletion/Duplication 600 acgh $990-1,490 3-M

More information

Mendelian inheritance and the

Mendelian inheritance and the Mendelian inheritance and the most common genetic diseases Cornelia Schubert, MD, University of Goettingen, Dept. Human Genetics EUPRIM-Net course Genetics, Immunology and Breeding Mangement German Primate

More information

4A. Types of Laboratory Tests Available and Specimens Required. Three main types of laboratory tests are used for diagnosing CHIK: virus

4A. Types of Laboratory Tests Available and Specimens Required. Three main types of laboratory tests are used for diagnosing CHIK: virus 4. LABORATORY 4A. Types of Laboratory Tests Available and Specimens Required Three main types of laboratory tests are used for diagnosing CHIK: virus isolation, reverse transcriptase-polymerase chain reaction

More information

IMMEDIATE HOT LINE: Effective March 2, 2015

IMMEDIATE HOT LINE: Effective March 2, 2015 MEDICARE COVERAGE OF LABORATORY TESTING Please remember when ordering laboratory tests that are billed to Medicare/Medicaid or other federally funded programs, the following requirements apply: 1. Only

More information

TEST AND PRICE LIST FOR NEXT GENERATION SEQUENCING

TEST AND PRICE LIST FOR NEXT GENERATION SEQUENCING AIP ALK APC Mutation Detection Techniques Ai Saple Type TAT ATM BAP1 BLM BMPR1A BRCA1 BRCA2 BRIP1 BUB1B CDC73 CDH1 CDK4 CDKN1C CDKN2A CEBPA CEP57 CHEK2 CYLD DDB2 DICER1 DIS3L2 EGFR EPCAM ERCC2 ERCC3 ERCC4

More information

PART 2. ELECTRODIAGNOSTIC DIFFERENTIAL DIAGNOSIS OF COMMON

PART 2. ELECTRODIAGNOSTIC DIFFERENTIAL DIAGNOSIS OF COMMON PART 2. ELECTRODIAGNOSTIC DIFFERENTIAL DIAGNOSIS OF COMMON SYMPTOMS AND SIGNS 1. PAIN FACIAL PAIN " lesion of the trigeminal nerve " trigeminal neuralgia " facial nerve lesion NECK PAIN " C5 radiculopathy

More information

Single Gene and NextGen Panels

Single Gene and NextGen Panels Molecular Testing for Hearing Loss: Single Gene and NextGen Panels Honey V Reddi, PhD, FACMG Clinical Molecular Geneticist Prevention Genetics, Marshfield, WI www.preventiongenetics.com Outline of Presentation

More information

Reference Range: 0.5-1.6 mmol/l (arterial) 0.7-2.1 mmol/l (venous) CPT Code: 83605

Reference Range: 0.5-1.6 mmol/l (arterial) 0.7-2.1 mmol/l (venous) CPT Code: 83605 LACTIC ACID Fasting, arterial specimen preferred. Please note whether arterial or venous. 0.5 ml heparinized plasma. Green top or PST must be drawn, placed on ice, and spun within 15 minutes. Immediately

More information

L E A D I N G C N S A N T I B O D Y T E S T I N G S E R V I C E S

L E A D I N G C N S A N T I B O D Y T E S T I N G S E R V I C E S L E A D I N G C N S A N T I B O D Y T E S T I N G S E R V I C E S Paraneoplastic Autoimmune Neurological Disorder Testing Services New Tests Now Available. Why Athena Diagnostics? Faster, More Relevant

More information

The NeurOmics team at a recent project meeting

The NeurOmics team at a recent project meeting Introduction Welcome to the NeurOmics project newsletter. This is the second edition and comes after the project has been underway for just over a year. This means that whilst we still have lots of work

More information

CLINICAL GUIDELINES. Lab Management Program. Effective January 15, 2016

CLINICAL GUIDELINES. Lab Management Program. Effective January 15, 2016 CLINICAL GUIDELINES Lab Management Program Effective January 15, 2016 CareCore National, LLC d/b/a evicore healthcare (evicore) Clinical guidelines for medical necessity review of lab management services.

More information

2014 CPT Code Updates

2014 CPT Code Updates 2014 CPT Code Updates This publication is a summary of The American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory effective January 1, 2014.

More information

Limb girdle muscular dystrophies (LGMDs)

Limb girdle muscular dystrophies (LGMDs) Limb girdle muscular dystrophies (LGMDs) This factsheet is for all people for whom a diagnosis of limb girdle muscular dystrophy (LGMD) has been suggested. This is a complicated subject since there are

More information

NEALS Clinical Trials (Studies 1-5)

NEALS Clinical Trials (Studies 1-5) NEALS and NCRI Sample Repository Request Form Instructions & Descriptions The sample repository consists of serum, plasma, cerebrospinal fluid (CSF), urine, extracted DNA and whole blood samples from NEALS

More information

Tabella 1: PrenatalScreen - Elenco dei geni analizzati e della malattie genetiche investigate

Tabella 1: PrenatalScreen - Elenco dei geni analizzati e della malattie genetiche investigate Tabella 1: PrenatalScreen - Elenco dei geni analizzati e della malattie genetiche investigate MALATTIA PhenoMIM GENE 1 17-alpha-hydroxylase/17,20-lyase deficiency 202110 CYP17A1 2 17-beta-hydroxysteroid

More information

ICD-10 coding rules for rare diseases

ICD-10 coding rules for rare diseases October 2014 ICD-10 coding rules for rare diseases Procedural document www.orpha.net Table of contents Table of contents... 2 General points... 3 I. Purpose... 3 II. Reference documents... 3 III. Range

More information

NORD Guides for Physicians #1. Physician s Guide to. Tyrosinemia. Type 1

NORD Guides for Physicians #1. Physician s Guide to. Tyrosinemia. Type 1 NORD Guides for Physicians #1 The National Organization for Rare Disorders Physician s Guide to Tyrosinemia Type 1 The original version of this booklet was made possible by donations in honor of Danielle

More information

Launching a Cancer Genetic Laboratory to Enhance Diagnosis and Treatment

Launching a Cancer Genetic Laboratory to Enhance Diagnosis and Treatment Launching a Cancer Genetic Laboratory to Enhance Diagnosis and Treatment Arthur L. Beaudet, M.D. Department of Molecular and Human Genetics Baylor College of Medicine ORIGIN AND PRECEDENT Decades of experience

More information

ICD-9 to ICD-10 Conversion Commonly Used Neurologic Diagnosis

ICD-9 to ICD-10 Conversion Commonly Used Neurologic Diagnosis ICD-9 to ICD-10 Conversion Commonly Used Neurologic Diagnosis 327.20 Organic sleep apnea, unspecified... 1 331.0 Alzheimer s disease...3 333.1 Essential and other specified forms of tremor...4 340 Multiple

More information

Molecular Genetic Testing in Public Health and Clinical Settings

Molecular Genetic Testing in Public Health and Clinical Settings Molecular Genetic Testing in Public Health and Clinical Settings Ira M. Lubin, PhD, FACMG Division of Laboratory Systems NCPDCID, CCID Centers for Disease Control and Prevention Atlanta, Georgia Disclaimers

More information

July 2015 - Monthly Update, Quest Diagnostics Nichols Institute, Valencia

July 2015 - Monthly Update, Quest Diagnostics Nichols Institute, Valencia TEST CHANGES Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Former Test Name Effective Date

More information

Next-generation sequencing can replace Sanger sequencing in clinical diagnostics.

Next-generation sequencing can replace Sanger sequencing in clinical diagnostics. Next-generation sequencing can replace Sanger sequencing in clinical diagnostics. Birgit Sikkema-Raddatz Department of Genetics, University Medical Center Groningen The Netherlands Groningen GRONINGEN

More information

Facts About. Mitochondrial. Myopathies

Facts About. Mitochondrial. Myopathies Facts About Mitochondrial Myopathies Updated December 2009 The Kelly family at the MDA Labor Day Telethon. Dear Friends: If you are reading this booklet, it s probably because you ve just received a very

More information

Neuromuscular Medicine Fellowship Curriculum

Neuromuscular Medicine Fellowship Curriculum Neuromuscular Medicine Fellowship Curriculum General Review Goals and Objectives Attend weekly EMG sessions as assigned Take a Directed History and Exam of each EMG patient Attend every other week Muscle

More information

1199 SEIU Benefit Funds Laboratory Management Program PRIOR AUTHORIZATION CODE LIST FOR OUTPATIENT MOLECULAR AND GENOMIC LABORATORY TESTS

1199 SEIU Benefit Funds Laboratory Management Program PRIOR AUTHORIZATION CODE LIST FOR OUTPATIENT MOLECULAR AND GENOMIC LABORATORY TESTS 1199 SEIU Benefit Funds Laboratory Management Program PRIOR AUTHORIZATION CODE LIST FOR OUTPATIENT MOLECULAR AND GENOMIC LABORATORY TESTS Effective January 1, 2016 Administered by evicore healthcare Refer

More information

Corporate Medical Policy Genetic Testing for Hereditary Hearing Loss

Corporate Medical Policy Genetic Testing for Hereditary Hearing Loss Corporate Medical Policy Genetic Testing for Hereditary Hearing Loss File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_hereditary_hearing_loss 10/2013 8/2015 8/2016

More information

Please note: Contact Coppe Laboratories at 262-574-0701 if archival plasma samples need to be tested.

Please note: Contact Coppe Laboratories at 262-574-0701 if archival plasma samples need to be tested. Collecting a Coppe Laboratories Sample The Coppe Laboratories Sample Kit contains: Test Request Form (TRF) Heparin tube Absorbent sheet Biohazard bag Foil pouch Label for blood tube Box Seal Instructions

More information

G. Shashidhar Pai, MD MUSC Children s Hospital Department of Pediatrics Division of Genetics

G. Shashidhar Pai, MD MUSC Children s Hospital Department of Pediatrics Division of Genetics G. Shashidhar Pai, MD MUSC Children s Hospital Department of Pediatrics Division of Genetics One of every 500 newborns has bilateral permanent sensorineural hearing loss 40 db which makes it the most common

More information

Case Study: John Woodbury

Case Study: John Woodbury Case Presentation John is 44 years old. He is sitting in the chair in the examination room. As he moves to the table, he stumbles on the carpet, laughs at himself and says that happens all the time. John

More information

Targeted Variant Test Requisition Form (3/4/2015)

Targeted Variant Test Requisition Form (3/4/2015) Targeted Variant Test Requisition Form (3/4/2015) Instructions: Please provide clinical features of family members. All testing must be ordered by a qualified healthcare provider. See Test Selection Box

More information

Fatty Acid Oxidation Disorders Galactosemia Biotinidase Deficiency

Fatty Acid Oxidation Disorders Galactosemia Biotinidase Deficiency Fatty Acid Oxidation Disorders Galactosemia Biotinidase Deficiency Dr. Kathy Grange, MD Division of Genetics and Genomic Medicine Department of Pediatrics Washington University School of Medicine What

More information

UNDERSTANDING MULTIPLE MYELOMA AND LABORATORY VALUES Benjamin Parsons, DO bmparson@gundersenhealth.org Gundersen Health System Center for Cancer and

UNDERSTANDING MULTIPLE MYELOMA AND LABORATORY VALUES Benjamin Parsons, DO bmparson@gundersenhealth.org Gundersen Health System Center for Cancer and UNDERSTANDING MULTIPLE MYELOMA AND LABORATORY VALUES Benjamin Parsons, DO bmparson@gundersenhealth.org Gundersen Health System Center for Cancer and Blood Disorders La Crosse, WI UNDERSTANDING MULTIPLE

More information

Nouvelles méthodes de diagnostic génétique des maladies mitochondriales

Nouvelles méthodes de diagnostic génétique des maladies mitochondriales Nouvelles méthodes de diagnostic génétique des maladies mitochondriales Mitochondrial disorders 1/8000 live birth Primary mitochondrial disorders Mutations in 80 nuclear genes Mutations in 13 mitochondrial

More information

dagan.wells@obs gyn.ox.ac.ukgyn.ox.ac.uk

dagan.wells@obs gyn.ox.ac.ukgyn.ox.ac.uk In vitro fertilisation and genetic testing Dagan Wells, PhD, FRCPath dagan.wells@obs gyn.ox.ac.ukgyn.ox.ac.uk Infertility Unprotected intercourse for 1 year without conception Very common 1 in 6 couples

More information

Co-pay assistance organizations offering assistance

Co-pay assistance organizations offering assistance Acromegaly Acute Exacerbations of Multiple Sclerosis Acute Porphyrias Advanced Idiopathic Parkinson' s Disease Age-Related Macular Degeneration www.theassistancefund.org Alcohol Dependence Alpha-1 Antitrypsin

More information

Test Information Sheet

Test Information Sheet Test Information Sheet GeneDx 207 Perry Parkway Gaithersburg, MD 20877 Phone: 888-729-1206 Fax: 301-710-6594 E-mail: wecare@genedx.com www.genedx.com/oncology OncoGene Dx: Breast/Ovarian Cancer Panel Sequence

More information

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge. Complete Blood Count CPT Code: CBC with Differential: 85025 CBC without Differential: 85027 Order Code: CBC with Differential: C915 Includes: White blood cell, Red blood cell, Hematocrit, Hemoglobin, MCV,

More information

The Genetics of Early- Onset Breast Cancer. Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine

The Genetics of Early- Onset Breast Cancer. Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine The Genetics of Early- Onset Breast Cancer Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine All cancers are genetic BUT Not all cancers are hereditary

More information

GENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED207.110

GENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED207.110 GENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED207.110 COVERAGE: Pre- and post-genetic test counseling may be eligible for coverage in addition to the genetic

More information

Validation parameters: An introduction to measures of

Validation parameters: An introduction to measures of Validation parameters: An introduction to measures of test accuracy Types of tests All tests are fundamentally quantitative Sometimes we use the quantitative result directly However, it is often necessary

More information

2013/14 NHS STANDARD CONTRACT FOR DIAGNOSTIC SERVICE FOR RARE NEUROMUSCULAR DISORDERS (ALL AGES)

2013/14 NHS STANDARD CONTRACT FOR DIAGNOSTIC SERVICE FOR RARE NEUROMUSCULAR DISORDERS (ALL AGES) D04/S(HSS)/a 2013/14 NHS STANDARD CONTRACT FOR DIAGNOSTIC SERVICE FOR RARE NEUROMUSCULAR DISORDERS (ALL AGES) PARTICULARS, SCHEDULE 2 THE SERVICES, A - SERVICE SPECIFICATIONS Service Specification No.

More information

3nd Biennial Contemporary Clinical Neurophysiological Symposium October 12, 2013 Fundamentals of NCS and NMJ Testing

3nd Biennial Contemporary Clinical Neurophysiological Symposium October 12, 2013 Fundamentals of NCS and NMJ Testing 3nd Biennial Contemporary Clinical Neurophysiological Symposium October 12, 2013 Fundamentals of NCS and NMJ Testing Peter D. Donofrio, M.D. Professor of Neurology Vanderbilt University Medical Center

More information

P R O D U C T S CATALOG 2011-2012

P R O D U C T S CATALOG 2011-2012 P R O D U C T S CATALOG 2011-2012 INSTITUTE FOR THE APPLICATION OF NUCLEAR ENERGY - INEP Banatska 31b 11080 Zemun Belgrade Serbia Tel: (+381 11) 2619 252, 2618 696, 2199 949 Fax: (+381 11) 2618 724 www.inep.co.rs

More information

Common Cancers & Hereditary Syndromes

Common Cancers & Hereditary Syndromes Common Cancers & Hereditary Syndromes Elizabeth Hoodfar, MS, LCGC Regional Cancer Genetics Coordinator Kaiser Permanente Northern California Detect clinical characteristics of hereditary cancer syndromes.

More information

Testing for RA. The Ideal Lab Test. William M. Wason, MD, PhD 9/24/2010. Confusion Abounds

Testing for RA. The Ideal Lab Test. William M. Wason, MD, PhD 9/24/2010. Confusion Abounds Confusion Abounds Rheumatoid arthritis: ulnar deviation and muscle artrophy, hands Poor sensitivity and specificity Hepatitis C causes lots of false + tests Changing technology in how tests are done Historic

More information

How To Treat The Sando Syndrome

How To Treat The Sando Syndrome Consultation on Drugs for Rare Diseases Rare Disease Day Symposium Hannover Medical School (MHH), Solidarity Rare but Strong Together Roland Seifert, MHH @ Dear Sir, I am writing hoping that there might

More information

Approaches to Integrating Next Generation Sequencing into the Electronic Health Record

Approaches to Integrating Next Generation Sequencing into the Electronic Health Record AMIA Webinar April 16, 2014 Approaches to Integrating Next Generation Sequencing into the Electronic Health Record Peter Tarczy-Hornoch, University of Washington On behalf of the Clinical Sequencing Exploratory

More information

EBiSC: The European Bank for induced pluripotent Stem Cells

EBiSC: The European Bank for induced pluripotent Stem Cells EBiSC: The European Bank for induced pluripotent Stem Cells Sadallah Fatiha 30.10.2014 Japan Health Sciences Foundation Visit IMI JU Office, Brussels, Belgium EBiSC Establish a European repository for

More information

The challenges of conducting clinical development in rare / orphan diseases: The Industry Perspective

The challenges of conducting clinical development in rare / orphan diseases: The Industry Perspective The challenges of conducting clinical development in rare / orphan diseases: The Industry Perspective Thomas Meier, PhD (Chief Scientific Officer) Muscle Study Group, September 22, 2009 Agenda Santhera

More information

About The Causes of Hearing Loss

About The Causes of Hearing Loss About 1 in 500 infants is born with or develops hearing loss during early childhood. Hearing loss has many causes: some are genetic (that is, caused by a baby s genes) or non-genetic (such as certain infections

More information

CANADIAN RULE BASED CLASSIFICATION SYSTEM (IVDD) Life Sciences British Columbia NRC-Industry Research Assistance Program

CANADIAN RULE BASED CLASSIFICATION SYSTEM (IVDD) Life Sciences British Columbia NRC-Industry Research Assistance Program CANADIAN RULE BASED CLASSIFICATION SYSTEM (IVDD) Life Sciences British Columbia NRC-Industry Research Assistance Program Health Canada Regulations on Medical Devices Vancouver, B.C. October 29, 2007 Nancy

More information

Please leave this space blank

Please leave this space blank Please leave this space blank REQUEST FORM EXOME SEQUENCING Radboudumc 848 Human Genetics / Genome diagnostics Postbus 9101 6500 HB Nijmegen, The Netherlands Laboratory head: Dr. H. Yntema Tel : 0031-(0)24-3613799

More information

***Next Generation sequencing testing options available effective April 18 th, 2016***

***Next Generation sequencing testing options available effective April 18 th, 2016*** ***Next Generation sequencing testing options available effective April 18 th, 2016*** Genetic Test Next Generation Sequencing NF1-RASopathy Panel Testing NF1-only NGS testing and copy number analysis

More information

GENETIC TESTING AND MARFAN SYNDROME

GENETIC TESTING AND MARFAN SYNDROME GENETIC TESTING AND MARFAN SYNDROME Genetic testing for mutations in fibrillin-1 (FBN1) and other genes has become an important and reliable option to aid in the diagnosis of Marfan syndrome and related

More information

Zika Virus. Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases

Zika Virus. Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases Zika Virus Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases What is the incubation period for Zika virus infection? Unknown but likely to be several

More information

Pediatric Neuromuscular Disorders: Transitions to Adult Providers

Pediatric Neuromuscular Disorders: Transitions to Adult Providers Pediatric Neuromuscular Disorders: Transitions to Adult Providers 29 th Annual Update in Physical Medicine and Rehabilitation January 29, 2015 Russell Butterfield MD, PhD Assistant Professor, Departments

More information

Facts About. Metabolic. Diseases of Muscle

Facts About. Metabolic. Diseases of Muscle Facts About Metabolic Diseases of Muscle Updated December 2009 Keith Stout Dear Friends: If you ve just learned that you or a loved one has a metabolic muscle disorder, you re probably both relieved and

More information

Patient Information. Ordering Physician Information. Indication for Testing (REQUIRED)

Patient Information. Ordering Physician Information. Indication for Testing (REQUIRED) EPILEPSY EXOME CLINICAL CHECKLIST REQUIRED Please check all clinical features that apply, and use the additional space provided at the bottom of the form if needed Patient Information Name: Last First

More information

A Source of Hard- to- Find Pa3ents and Caregivers For Researchers. Peter Ziedins Peter.ziedins@mpiresearch.ca 514-426- 9295 www.rarepa;entvoice.

A Source of Hard- to- Find Pa3ents and Caregivers For Researchers. Peter Ziedins Peter.ziedins@mpiresearch.ca 514-426- 9295 www.rarepa;entvoice. A Source of Hard- to- Find Pa3ents and Caregivers For Researchers Peter Ziedins Peter.ziedins@mpiresearch.ca 514-426- 9295 www.rarepa;entvoice.com About RPV Rare Pa3ent Voice, LLC was formed to provide

More information

Corporate Medical Policy Carrier Testing for Genetic Disease

Corporate Medical Policy Carrier Testing for Genetic Disease Corporate Medical Policy Carrier Testing for Genetic Disease File Name: Origination: Last CAP Review: Next CAP Review: Last Review: carrier_testing_for_genetic_disease 12/2013 8/2015 8/2016 8/2015 Description

More information

Genetic Testing in Research & Healthcare

Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research and Healthcare Human genetic testing is a growing science. It is used to study genes

More information

Systemic Lupus Erythematosus

Systemic Lupus Erythematosus Harvard-MIT Division of Health Sciences and Technology HST.021: Musculoskeletal Pathophysiology, IAP 2006 Course Director: Dr. Dwight R. Robinson Systemic Lupus Erythematosus A multi-system autoimmune

More information

Muscular dystrophy clinical manifestations: progressive proximal extremity weakness respiratory muscle weakness cardiomyopathy

Muscular dystrophy clinical manifestations: progressive proximal extremity weakness respiratory muscle weakness cardiomyopathy Muscular dystrophy clinical manifestations: progressive proximal extremity weakness respiratory muscle weakness cardiomyopathy Muscular dystrophy pathology: muscle fiber degeneration and regeneration Muscular

More information

ANA testing can now be ordered in several ways, depending on the clinical circumstances:

ANA testing can now be ordered in several ways, depending on the clinical circumstances: LAB TEST CONNECT Multiplex ANA Screen Dr. Joseph Schappert, M.D.,Medical Director Chief Medical Offi cer ANA has been the primary screening test for connective tissue diseases (CTD s) for many years. While

More information

UNIT 13 (OPTION) Genetic Abnormalities

UNIT 13 (OPTION) Genetic Abnormalities Unit 13 Genetic Abnormailities 1 UNIT 13 (OPTION) Genetic Abnormalities Originally developed by: Hildur Helgedottir RN, MN Revised (2000) by: Marlene Reimer RN, PhD, CCN (C) Associate Professor Faculty

More information

Gene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press

Gene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press Gene Therapy The use of DNA as a drug Edited by Gavin Brooks BPharm, PhD, MRPharmS (PP) Pharmaceutical Press Contents Preface xiii Acknowledgements xv About the editor xvi Contributors xvii An introduction

More information

BRCA1 / 2 testing by massive sequencing highlights, shadows or pitfalls?

BRCA1 / 2 testing by massive sequencing highlights, shadows or pitfalls? BRCA1 / 2 testing by massive sequencing highlights, shadows or pitfalls? Giovanni Luca Scaglione, PhD ------------------------ Laboratory of Clinical Molecular Diagnostics and Personalized Medicine, Institute

More information

LAB MANAGEMENT CRITERIA. 1199SEIU Funds. Effective July 16, 2015

LAB MANAGEMENT CRITERIA. 1199SEIU Funds. Effective July 16, 2015 LAB MANAGEMENT CRITERIA 1199SEIU Funds Effective July 16, 2015 Clinical criteria for medical necessity review of lab management services. Please note the following: CPT Copyright 2015 American Medical

More information

***Next Generation sequencing testing options available effective April 18 th, 2016***

***Next Generation sequencing testing options available effective April 18 th, 2016*** ***Next Generation sequencing testing options available effective April 18 th, 2016*** Genetic Test Next Generation Sequencing NF1-RASopathy Panel Testing NF1-only NGS testing and copy number analysis

More information

Medical Necessity and Advanced Beneficiary Notice (ABN) Policy and Form

Medical Necessity and Advanced Beneficiary Notice (ABN) Policy and Form Medical Necessity and Advanced Beneficiary Notice (ABN) Policy and Form Billings Clinic Laboratory believes all health-care providers should order only appropriate tests for the diagnosis and treatment

More information

Neurological System Best Practice Documentation

Neurological System Best Practice Documentation Neurological System Best Practice Documentation Click on the desired Diagnoses link or press Enter to view all information. Diagnoses: Dementia Delirium/Encephalopathy Parkinson s Epilepsy /Seizure Migraines

More information

Multiple Myeloma Patient s Booklet

Multiple Myeloma Patient s Booklet 1E Kent Ridge Road NUHS Tower Block, Level 7 Singapore 119228 Email : ncis@nuhs.edu.sg Website : www.ncis.com.sg LIKE US ON FACEBOOK www.facebook.com/ nationaluniversitycancerinstitutesingapore Multiple

More information

Medical Devices; Exemptions From Premarket Notifications; Class II Devices; Autosomal

Medical Devices; Exemptions From Premarket Notifications; Class II Devices; Autosomal This document is scheduled to be published in the Federal Register on 10/27/2015 and available online at http://federalregister.gov/a/2015-27198, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Laboratory User Guides

Laboratory User Guides CLINICAL GENETIC SERVICE Laboratory User Guides (Website version) January 2016 DEPARTMENT OF HEALTH GOVERNMENT OF HONG KONG SAR Page 1 of 10 Compared with the previous version of January 2015, several

More information

Becker Muscular Dystrophy

Becker Muscular Dystrophy Muscular Dystrophy A Case Study of Positional Cloning Described by Benjamin Duchenne (1868) X-linked recessive disease causing severe muscular degeneration. 100 % penetrance X d Y affected male Frequency

More information

How To Test For Creatinine

How To Test For Creatinine Creatinine is measured amperometrically. Creatinine is hydrolyzed to creatine in a reaction catalyzed by the enzyme creatinine amidohydrolase. Creatine is then hydrolyzed to sarcosine in a reaction catalyzed

More information

Organisation of Biochemical Genetic Testing in Estonia

Organisation of Biochemical Genetic Testing in Estonia Organisation of Biochemical Genetic Testing in Estonia Katrin Õunap Department of Pediatrics, University of Tartu Department of Genetics, Tartu University Hospital Basel, 09 th May 2008 ESTONIA 1,35 million

More information

Minicore (multicore) myopathy

Minicore (multicore) myopathy Minicore (multicore) myopathy Minicore myopathy, also called, multicore myopathy and multiminicore myopathy, falls under the umbrella of congenital myopathies. These are a group of conditions characterised

More information

Protein electrophoresis is used to categorize globulins into the following four categories:

Protein electrophoresis is used to categorize globulins into the following four categories: Globulin Globulin is one of the two types of serum proteins, the other being albumin. This generic term encompasses a heterogeneous series of families of proteins, with larger molecules and less soluble

More information

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia INTRODUCTION Thrombophilia (Hypercoagulability) is a condition in which a person forms blood clots more than normal. Blood clots may occur in the arms or legs (e.g., deep vein thrombosis DVT), the lungs

More information

What Is Genetic Counseling? Helping individuals and families understand how genetics affects their health and lives

What Is Genetic Counseling? Helping individuals and families understand how genetics affects their health and lives What Is Genetic Counseling? Helping individuals and families understand how genetics affects their health and lives What does the career involve? Explore family histories to identify risks Reducing risks

More information

University of Cincinnati and Cincinnati Children s Hospital Medical Center. Genetic Counseling Program M.S.

University of Cincinnati and Cincinnati Children s Hospital Medical Center. Genetic Counseling Program M.S. University of Cincinnati and Cincinnati Children s Hospital Medical Center Genetic Counseling Program M.S. What is genetic counseling? Genetic counseling is the process of helping people understand and

More information

Allied, Therapeutic and Psychology Extender Benefit

Allied, Therapeutic and Psychology Extender Benefit Allied, Therapeutic and Psychology Extender Benefit 2013 The Allied, Therapeutic and Psychology Extender Benefit is available on the Enhanced Option only. Overview This document tells you about the Allied,

More information

CRITICAL ILLNESS INSURANCE for the Employees of Kellogg Community College

CRITICAL ILLNESS INSURANCE for the Employees of Kellogg Community College CRITICAL ILLNESS INSURANCE for the Employees of Kellogg Community College Eligibility How Much Can You Buy? Guaranteed Issue Covered Conditions and Benefit Amount Percentage Offered by Life Insurance Company

More information

INTRODUCTION TO THE UK CURRICULUM IN CLINICAL GENETICS

INTRODUCTION TO THE UK CURRICULUM IN CLINICAL GENETICS INTRODUCTION TO THE UK CURRICULUM IN CLINICAL GENETICS Clinical Geneticists work in multidisciplinary regional genetic centres in the UK, in close collaboration with laboratory scientists, clinical co-workers

More information

HEART GENE PANEL DG 2.3.x

HEART GENE PANEL DG 2.3.x HEART GENE PANEL DG 2.3.x Gene Median % covered > % covered > Associated Phenotype description and OMIM ID coverage 10x 20x AARS2 94,1 99% 98% Combined oxidative phosphorylation deficiency 8, 614096 ABCC6

More information

Genetic Tests and Disease States Included in Humana s Genetic Guidance Program

Genetic Tests and Disease States Included in Humana s Genetic Guidance Program 81161 81200 81201 Dystrophin (DMD) (e.g., Duchenne/Becker muscular dystrophy) deletion analysis and duplication analysis, if performed Aspartoacylase (ASPA) (e.g., Canavan disease) gene analysis, common

More information